236 related articles for article (PubMed ID: 32791162)
1. Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians.
Wang CW; Tassaneeyakul W; Chen CB; Chen WT; Teng YC; Huang CY; Sukasem C; Lu CW; Lee YS; Choon SE; Nakkam N; Hui RC; Huang YH; Chang YC; Lin YY; Chang CJ; Chiu TM; Chantratita W; Konyoung P; Lee CN; Klaewsongkram J; Rerkpattanapipat T; Amornpinyo W; Saksit N; Rerknimitr P; Huang YH; Lin SH; Hsu CK; Chan CC; Lin YJ; Hung SI; Chung WH;
J Allergy Clin Immunol; 2021 Apr; 147(4):1402-1412. PubMed ID: 32791162
[TBL] [Abstract][Full Text] [Related]
2. Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes.
Sukasem C; Pratoomwun J; Satapornpong P; Klaewsongkram J; Rerkpattanapipat T; Rerknimitr P; Lertpichitkul P; Puangpetch A; Nakkam N; Konyoung P; Khunarkornsiri U; Disphanurat W; Srisuttiyakorn C; Pattanacheewapull O; Kanjanawart S; Kongpan T; Chumworathayi P; Saksit N; Bruminhent J; Tassaneeyakul W; Chantratita W; Pirmohamed M
Clin Pharmacol Ther; 2020 Nov; 108(5):1078-1089. PubMed ID: 32452529
[TBL] [Abstract][Full Text] [Related]
3. Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions.
Kongpan T; Mahasirimongkol S; Konyoung P; Kanjanawart S; Chumworathayi P; Wichukchinda N; Kidkeukarun R; Preechakul S; Khunarkornsiri U; Bamrungram W; Supharatwattanakun B; Mootsikapun P; Kwangsukstid S; Denjanta S; Vannaprasaht S; Rungapiromnan W; Suwankesawong W; Tassaneeyakul W; Tassaneeyakul W
Pharmacogenet Genomics; 2015 Aug; 25(8):402-11. PubMed ID: 26086150
[TBL] [Abstract][Full Text] [Related]
4. Genotypic and Phenotypic Characteristics of Co-Trimoxazole-Induced Cutaneous Adverse Reactions.
Iamsumang W; Chanprapaph K; Sukasem C; Satapornpong P; Thadanipon K; Suchonwanit P; Jantararoungtong T; Anuntrangsee T
Dermatology; 2023; 239(6):966-975. PubMed ID: 37793359
[TBL] [Abstract][Full Text] [Related]
5. Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions.
Nakkam N; Saksit N; Konyoung P; Amornpinyo W; Khunarkornsiri U; Purimart D; Pattanacheewapull O; Naewla T; Wattanachai P; Khaeso K; Chumworathayi P; Tassaneeyakul W
Drug Metab Pharmacokinet; 2022 Dec; 47():100480. PubMed ID: 36379177
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants associated with phenytoin-related severe cutaneous adverse reactions.
Chung WH; Chang WC; Lee YS; Wu YY; Yang CH; Ho HC; Chen MJ; Lin JY; Hui RC; Ho JC; Wu WM; Chen TJ; Wu T; Wu YR; Hsih MS; Tu PH; Chang CN; Hsu CN; Wu TL; Choon SE; Hsu CK; Chen DY; Liu CS; Lin CY; Kaniwa N; Saito Y; Takahashi Y; Nakamura R; Azukizawa H; Shi Y; Wang TH; Chuang SS; Tsai SF; Chang CJ; Chang YS; Hung SI; ;
JAMA; 2014 Aug; 312(5):525-34. PubMed ID: 25096692
[TBL] [Abstract][Full Text] [Related]
7. Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population.
Tassaneeyakul W; Prabmeechai N; Sukasem C; Kongpan T; Konyoung P; Chumworathayi P; Tiamkao S; Khunarkornsiri U; Kulkantrakorn K; Saksit N; Nakkam N; Satapornpong P; Vannaprasaht S; Sangviroon A; Mahasirimongkol S; Wichukchinda N; Rerkpattanapipat T; Tassaneeyakul W
Pharmacogenet Genomics; 2016 May; 26(5):225-34. PubMed ID: 26928377
[TBL] [Abstract][Full Text] [Related]
8. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians.
Chen CB; Hsiao YH; Wu T; Hsih MS; Tassaneeyakul W; Jorns TP; Sukasem C; Hsu CN; Su SC; Chang WC; Hui RC; Chu CY; Chen YJ; Wu CY; Hsu CK; Chiu TM; Sun PL; Lee HE; Yang CY; Kao PH; Yang CH; Ho HC; Lin JY; Chang YC; Chen MJ; Lu CW; Ng CY; Kuo KL; Lin CY; Yang CS; Chen DP; Chang PY; Wu TL; Lin YJ; Weng YC; Kuo TT; Hung SI; Chung WH;
Neurology; 2017 Jan; 88(1):78-86. PubMed ID: 27913699
[TBL] [Abstract][Full Text] [Related]
9. Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing
Pratoomwun J; Thomson P; Jaruthamsophon K; Tiyasirichokchai R; Jinda P; Rerkpattanapipat T; Tassaneeyakul W; Nakkam N; Rerknimitr P; Klaewsongkram J; Srinoulprasert Y; Pirmohamed M; Naisbitt DJ; Sukasem C
Front Immunol; 2021; 12():658593. PubMed ID: 33995375
[No Abstract] [Full Text] [Related]
10. Cost-effectiveness analysis of HLA-B*13:01 screening for the prevention of co-trimoxazole-induced severe cutaneous adverse reactions among HIV-infected patients in Thailand.
Kategeaw W; Nakkam N; Kiertiburanakul S; Sukasem C; Tassaneeyakul W; Chaiyakunapruk N
J Med Econ; 2023; 26(1):1330-1341. PubMed ID: 37830976
[TBL] [Abstract][Full Text] [Related]
11. Human Leukocyte Antigens and Sulfamethoxazole/Cotrimoxazole-Induced Severe Cutaneous Adverse Reactions: A Systematic Review and Meta-Analysis.
Wu PC; Chen WT; Huang IH; Chen CB; Wang CW; Tai CC; Chung WH; Chi CC
JAMA Dermatol; 2024 May; 160(5):525-534. PubMed ID: 38568509
[TBL] [Abstract][Full Text] [Related]
12. Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population.
Chang CC; Too CL; Murad S; Hussein SH
Int J Dermatol; 2011 Feb; 50(2):221-4. PubMed ID: 21244392
[TBL] [Abstract][Full Text] [Related]
13. Association of HLA genotypes with phenobarbital hypersensitivity in children.
Manuyakorn W; Mahasirimongkol S; Likkasittipan P; Kamchaisatian W; Wattanapokayakit S; Inunchot W; Visudtibhan A; Wichukchinda N; Benjaponpitak S
Epilepsia; 2016 Oct; 57(10):1610-1616. PubMed ID: 27554620
[TBL] [Abstract][Full Text] [Related]
14. HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese.
Cheung YK; Cheng SH; Chan EJ; Lo SV; Ng MH; Kwan P
Epilepsia; 2013 Jul; 54(7):1307-14. PubMed ID: 23692434
[TBL] [Abstract][Full Text] [Related]
15. Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs.
Klaewsongkram J; Sukasem C; Thantiworasit P; Suthumchai N; Rerknimitr P; Tuchinda P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C;
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):219-227.e4. PubMed ID: 29800753
[TBL] [Abstract][Full Text] [Related]
16. HLA alleles and hypersensitivity to carbamazepine: an updated systematic review with meta-analysis.
Grover S; Kukreti R
Pharmacogenet Genomics; 2014 Feb; 24(2):94-112. PubMed ID: 24336023
[TBL] [Abstract][Full Text] [Related]
17. The risk of anti-osteoporotic agent-induced severe cutaneous adverse drug reactions and their association with HLA.
Chen CB; Chen YE; Chu MT; Wang CW; Hui RC; Lu CW; Hsiao YP; Chu CY; Chang MM; Cheung CM; Cheng CY; Wang YW; Lin YJ; Chang CJ; Hung SI; Chung WH;
J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):712-720. PubMed ID: 32896010
[TBL] [Abstract][Full Text] [Related]
18. Association of the diplotype configuration at the N-acetyltransferase 2 gene with adverse events with co-trimoxazole in Japanese patients with systemic lupus erythematosus.
Soejima M; Sugiura T; Kawaguchi Y; Kawamoto M; Katsumata Y; Takagi K; Nakajima A; Mitamura T; Mimori A; Hara M; Kamatani N
Arthritis Res Ther; 2007; 9(2):R23. PubMed ID: 17335581
[TBL] [Abstract][Full Text] [Related]
19. Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients.
Sukasem C; Chaichan C; Nakkrut T; Satapornpong P; Jaruthamsophon K; Jantararoungtong T; Koomdee N; Sririttha S; Medhasi S; Oo-Puthinan S; Rerkpattanapipat T; Klaewsongkram J; Rerknimitr P; Tuchinda P; Chularojanamontri L; Tovanabutra N; Puangpetch A; Aekplakorn W
J Immunol Res; 2018; 2018():2780272. PubMed ID: 29546073
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation of ITGB2 contributes to allopurinol hypersensitivity.
Liu Y; Wang CW; Chen CB; Yu KH; Wu YJ; Choon SE; Chang WC; Yang F; Luo XQ; Chung WH; Zhao M; Lu QJ
Clin Immunol; 2023 Mar; 248():109250. PubMed ID: 36738816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
